ANTIVIRAL DRUGS ADVISORY COMMITTEE
July 27, 1999
Slides
Rosemary Tiernan, M.D.Maureen D. Skowronek,
Wyeth-Ayerst Research
Regulatory Phase I and II Studies Pharmacokinetics DesignBarry D. Kahan, PhD, MD,
University of Texas School of Medicine, Houston
EfficacyJoseph Camardo, MD
Wyeth-Ayerst Research
Safety Conclusions